Past CureTalks
What you need to know about the ICER report and its implication on insurance coverage and treatment options for myeloma patients.
Cancer drugs cost more than $100,000 per year and continue to increase. Medicare has proposed major changes to Medicare Part B in an attempt to slow the explosion in healthcare expenditures. In addition, a recent “report” by a group called…
How Old is “Too Old” for Fertility?
Every woman feels the pressure of time when she has trouble getting pregnant, and running out of time keeps her worrying. The impact of age on fertility is a truth to reckon with, and age related fertility might be a…
The New Optimism of Combination Therapies in Multiple Myeloma Treatment.
Clinical trials of new combination therapies are showing promising results and can be a game changer in myeloma treatment - Combining standard drugs with monoclonal antibodies, t-cell therapies with stem cell transplants, myeloma vaccine combinations and more. We are talking…
Recurrent Miscarriages – Causes and Treatments
Almost half of all pregnancies end in a miscarriage, most of them occurring within few weeks of conception. While there are a number of known risk factors such as maternal age, history of miscarriage, and infertility, there are others like…
Everything you need to know about Daratumumab and Multiple Myeloma
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to…